Skip to main content
About HEC About HEC Faculty & Research Faculty & Research Master’s programs Master’s programs MBA Programs MBA Programs PhD Program PhD Program Executive Education Executive Education Summer School Summer School HEC Online HEC Online About HEC Overview Overview Who
We Are Who
We Are
Egalité des chances Egalité des chances HEC Talents HEC Talents International International Campus
Life Campus
Sustainability Sustainability Diversity
& Inclusion Diversity
& Inclusion
Stories Stories The HEC
Foundation The HEC
Coronavirus Coronavirus
Faculty & Research Overview Overview Faculty Directory Faculty Directory Departments Departments Centers Centers Chairs Chairs Knowledge Knowledge Master’s programs Master in
Management Master in
Master in
International Finance Master in
International Finance
Masters Specialized
Ecole Polytechnique
-HEC programs Ecole Polytechnique
-HEC programs
programs Dual-Degree
students Visiting
Certificates Certificates Student
Life Student
MBA Programs MBA MBA Executive MBA Executive MBA TRIUM EMBA TRIUM EMBA PhD Program Overview Overview HEC Difference HEC Difference Program details Program details Research areas Research areas HEC Community HEC Community Placement Placement Job Market Job Market Admissions Admissions Financing Financing Executive Education Executive Masters Executive Masters Executive Certificates Executive Certificates Executive short programs Executive short programs Online Online Companies Companies Executive MBA Executive MBA Infinity Pass Infinity Pass Summer School Youth Programs Youth Programs Summer programs Summer programs HEC Online Overview Overview Degree Program Degree Program Executive certificates Executive certificates MOOCs MOOCs Summer Programs Summer Programs

Gad Berdugo

Director of Friends of HEC Inc.

Chief Business Officer, Editas Medicine


Gad Berdugo

His biography:

Gad Berdugo serves as Chief Business Officer at Editas Medicine. Mr. Berdugo has more than 25 years of biotech corporate development, business development, strategy, and financial experience. Among his prior roles, Mr. Berdugo held several executive-level positions for life science companies including serving most recently as CEO of EpiVax Oncology, Inc., a precision cancer immunotherapy company, which he co-founded in 2017; CFO at Nasdaq listed Immune Pharmaceuticals Inc.; Managing Director and Head of Life Sciences at Tegris Advisors LLC, a New York based advisory boutique where he led several cross-border M&As and strategic alliances mandates; and Founder and Managing Partner of the Explorium Global Healthcare Fund, providing growth capital to emerging biotech companies.

Mr. Berdugo received his MBA. from HEC Paris (exchange at Kellogg, Northwestern), his M.Sc. in Biochemical Engineering from University College London, and his B.Sc. with Honors in Biotechnology from Imperial College London. He currently serves on the board of directors of Genome Profiling LLC. 

He has been supporting the HEC Foundation for more 10 years.